THC Global Group Limited (ASX: THC) Information

THC Global Group Limited is an Australian publicly listed company on the Australian Stock Exchange (ASX Code: THC). THC is at the forefront of developing a leading, diversified worldwide cannabis business, focusing on two core business units: Development and delivery of medicinal cannabis, and manufacturing and distribution of hydroponics equipment, materials and nutrients. THC has also acquired a world-class pharmaceutical botanicals extraction and refinement facility in Queensland, Australia which will support the supply of medicinal cannabis to Australian patients in the near term and the global export market as approvals are obtained. A New Class of Medicinal Products: 17+ years in the breeding, variety selection and growth management of Cannabis sativa. Strategic Alliances: Alliances with a major European Medicinal Cannabis Supplier, Endoca and a leading Israeli medicinal cannabis developer. Fast tracking supply of Medicinal Cannabis in Australia. Prescriber and Patient and Pharmacy Access Programs: Canndeo is a foundational participant in the Medicinal Cannabis Medicines Portal (MCMP) which facilitates the prescribing and dispensing of medicinal cannabis products – www.mcmp.com.au Large scale, state-of-the-art biomanufacturing capabilities: Utilising modern extraction technology and a high-quality purification system that will enable production of a broad range of high quality, pure cannabinoids as Active Pharmaceutical Ingredients (API). 600+ Hydroponic Products: Over 600 Products and 9 established trademarks, with more products expected to be released in 2018 Growing Product Demand: North American cannabis industry experiencing 30-40% annual growth rates, driven by trend to legalize cannabis for both medicinal and recreational use. Experienced Management Team: We have a highly credentialed team, with a wealth of capital markets and listed company expertise, plus strong technical knowledge of the cannabis market.